OneDigital Investment Advisors 购买了 Viking Therapeutics 的股票，这是一家市值为 $5.86B 的生物制药公司。 OneDigital Investment Advisors buys shares in Viking Therapeutics, a biopharmaceutical firm with a $5.86B market cap.
OneDigital Investment Advisors LLC 收购了 Viking Therapeutics， Inc. 的 3,260 股股票，价值约 206,000 美元，与其他机构投资者一起修改了他们在该公司的股份。 OneDigital Investment Advisors LLC has acquired 3,260 shares in Viking Therapeutics, Inc., valued at around $206,000, joining other institutional investors in modifying their stakes in the company. Viking Therapeutics 是一家专门从事代谢和内分泌疾病治疗的生物制药公司，市值为 58.6 亿美元，目前正在进行其针对肝脏疾病的主导药物 VK2809 的 IIb 期试验。 Viking Therapeutics, a biopharmaceutical firm specializing in therapies for metabolic and endocrine disorders, has a market cap of $5.86 billion and is currently in Phase IIb trials for its lead drug, VK2809, targeting liver diseases. 尽管内部销售,但机构投资者拥有公司股票的76.03%,分析家有积极的前景,确定一致价格目标为109.73美元。 Despite insider sales, institutional investors own 76.03% of the company's stock, and analysts have a positive outlook, setting a consensus price target of $109.73.